Global Markets for Blood Plasma Products

Report Code: HLC201C

Publish Date: Mar 2023

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global blood plasma products market should reach $45.7 billion by 2027 from $33.2 billion in 2022 at a compound annual growth rate (CAGR) of 6.6% for the forecast period of 2022 to 2027.

Report Includes

  • 44 data tables and 30 additional tables
  • An overview of the global market for blood plasma products
  • Analyses of global market trends with data from 2020-2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Characterization and quantification of the global blood plasma products markets by product, application, mode of delivery, end user and geographical region
  • Detailed information related to mode of delivery for blood plasma
  • Analysis of key blood plasma products used in various therapeutic treatments as well as an examination of the supply chain from research to manufacturing
  • Coverage of segmentation of blood plasma products, including immunoglobulin, albumin, protease inhibitors, coagulation factor concentrates and other plasma fractionation products
  • In-depth analysis of the key strategies adopted by industry players, such as acquisition and geographical expansion
  • A look at major factors driving the growth of the global blood plasma products markets, including an organized network of donor centres and rising disease awareness and education
  • Profiles of the major players in the industry, including ADMA Biologics Inc., China Biologic Products Inc., Kedrion SpA, Octapharma AG, and Takeda Pharmaceutical Co. Ltd.

Report Scope

This research report presents an in-depth analysis of the global blood plasma products market by product type, application, end user and geographic market. In addition, the report provides qualitative information related to the mode of delivery for blood plasma.

The report includes key blood plasma products used in various therapeutic treatments as well as an examination of the supply chain from research to manufacturing. It also features an in-depth analysis of the key companies operating in the global blood plasma products market, and it surveys patents that highlight past, current and projected global technology trends. The blood plasma products market is primarily segmented into five major categories: immunoglobulin, albumin, hyperimmune globulin, coagulation factor concentrates, and other plasma fractionation products. Immunology, oncology, pulmonology, rheumatology, transplant, neurology, hematology and other applications are explained in the report. Products based on these applications are explored in detail and their influence on R&D is examined. In the analysis based on end users, the blood plasma products market is segmented into the following: hospitals and clinics, research laboratories, academic institutions and blood transfusion centers.

In terms of geography, the report analyzes the market across North America, Europe, Asia-Pacific and the Rest of the World (RoW). Key regions like the U.S., Canada, Europe (U.K., Italy, France, Germany), China, India, Australia and Japan are highlighted in the discussion due to a high concentration of blood plasma products manufacturing companies and contract manufacturing organizations in these areas. This report includes estimates of market size using 2021 as the base year and forecasting forward to 2027. Recent products launched by blood plasma products companies are studied and listed in the report. The estimated values that are used are based on the manufacturers’ total revenues.

A detailed analysis illustrating market dynamics and market structure is incorporated in the report. The market’s supply and distribution chain is discussed in detail in order to provide an in-depth understanding of the market. Top market players, along with details about their individual business operations and segment focus as well as analyses about their revenue and strategies, are included in the report. In addition, market share analysis of leading market players, product launches and pipeline products are provided.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022 to 2027
Base year market size $31.4 billion
Market size forecast $45.7 billion
Growth rate CAGR of 6.6% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered product type, application, end-user and region
Regions covered North America, Asia-Pacific, Europe, and Rest of the World
Countries covered U.S., Canada, U.K., Germany, France, Italy, Rest of Europe, China, India, Japan, Australia, and Rest of APAC
Key Market Drivers
  • Increasing Demand for Immunoglobulins in Therapeutic Treatments
  • Rising Prevalence of Alpha-1 Antitrypsin Deficiency (AATD)
  • Increased Geriatric Population Worldwide
  • Increase in Blood Donations
  • Increasing Use of Recombinant Plasma and Non-Plasma Based Products in Therapeutic Treatments
  • High Costs Associated with Blood Plasma Products
  • Stringent Government Regulations and Low Reimbursement Policies
  • Growing Investments in Plasma Fractionation Capacities
  • Increasing Research on New Formulations and Indications
  • Rising Incidence of Hemophilia
  • Opportunities in Emerging Nations
Companies studied
ADMA BIOLOGICS INC.BAXTER
BIO PRODUCTS LABORATORY LTD.TAIBANG BIOLOGICAL GROUP CO.
CSL BEHRINGGRIFOLS S.A.
INNOVATIVE RESEARCHINTAS PHARMACEUTICALS LTD.
KEDRION S.p.A.LFB S.A.
OCTAPHARMA AGSANQUIN
TAKEDA PHARMACEUTICAL CO. LTD.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS

Frequently Asked Questions (FAQs)

The blood plasma market is projected to grow from $31.4 billion in 2021 to $45.7 billion in 2027, at a compound annual growth rate (CAGR) of 6.6% during the forecast period.
The increasing demand for immunoglobulins in various therapies, the rising prevalence of Alpha-1 Antitrypsin Deficiency (AATD), and the increase in blood donations are responsible for market growth.
The blood plasma market is segmented on the product type, application, end-user and region.
Immunoglobulins segment will dominate the market by the end of 2027.
North America has the highest market share.
Grifols, Takeda, CSL, Kedrion, Octapharma, and LFB SA

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Latest reports include:
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Markets for Blood Plasma Products144Free
Chapter- 1: Introduction8Free
Chapter- 2: Summary and Highlights3Free
Chapter- 3: Market and Technology Background14Free
Chapter- 4: Market Breakdown by Product Type19Free
Chapter- 5: Market Breakdown by Application13Free
Chapter- 6: Market Breakdown by End User7Free
Chapter- 7: Market Breakdown by Region30Free
Chapter- 8: Mode of Delivery for Blood Plasma Products7Free
Chapter- 9: Patent Review and Clinical Trial Landscape5Free
Chapter- 10: Impact of the COVID-19 Pandemic on the Market for Blood Plasma Products2Free
Chapter- 11: Competitive Landscape8Free
Chapter- 12: Company Profiles28Free

Related Reports

Global Blood Platelet Market

Published - Jul 2025 | Publisher - BCC Publishing | Code - BIO268A

The global market for blood platelets is expected to grow from $3.2 billion in 2025 and is projected to reach $4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 4.6% during the forecast period of 2025 to 2030.

Biologic Therapeutic Drugs: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO079F

The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.

Global Markets and Manufacturing Technologies for Protein Drugs

Published - Apr 2025 | Publisher - BCC Publishing | Code - BIO021G

The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.

Antibody Drugs: Technologies and Global Markets

Published - Sep 2024 | Publisher - BCC Publishing | Code - BIO016M

The global market for antibody drugs is expected to grow from $242.6 billion in 2024 and is projected to reach $412.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.2% during the forecast period of 2024 to 2029.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 74

  • Summary Table: Global Market for Blood Plasma Products, by Product Type, Through 2027
  • Table 1: Blood Plasma Components
  • Table 2: Percentage of Major Proteins Present in Different Fractions After Cohn’s Fractionation Method
  • Table 3: Overview of Plasma Collection Operations Across Various Countries
  • Table 4: Global Market for Blood Plasma Products, by Product Type, Through 2027
  • Table 5: Global Market for Immunoglobulins, by Region, Through 2027
  • Table 6: Global Market for Immunoglobulins, by Product Subsegment, Through 2027
  • Table 7: Global Market for Intravenous Immunoglobulin, by Region, Through 2027
  • Table 8: Global Market for Subcutaneous Immunoglobulins, by Region, Through 2027
  • Table 9: Global Market for Other Immunoglobulins, by Region, Through 2027
  • Table 10: Global Market for Albumins, by Region, Through 2027
Sample Report

Recent Reports

6G in Healthcare: Global Market

Published - Jul 2025 | Publisher - BCC Publishing | Code - HLC306A

This report provides an analysis of the global market trends for 6G in healthcare. It focuses on the significant driving trends and challenges that affect the global market. The report concludes with an analysis of the competitive landscape, which provides the ranking/share of key companies in the global market for 6G in healthcare.

Healthcare Innovation in the GCC

Published - Jul 2025 | Publisher - BCC Publishing | Code - HLC307A

The report provides an analysis of the healthcare landscape in the Gulf Cooperation Council (GCC) countries. The report estimates the Total Addressable Market (TAM) for the GCC healthcare sector from 2024 to 2030, offering country-specific projections. This analysis provides critical insights into the commercial potential and investment opportunities in the region’s rapidly evolving healthcare ecosystem. The countries included in the analysis are Saudi Arabia, the United Arab Emirates (UAE), Qatar, Kuwait, Oman, and Bahrain.

Regional Analysis of the Beauty and Personal Care Market: Middle East and North Africa

Published - Jun 2025 | Publisher - BCC Publishing | Code - HLC305A

This report presents an in-depth analysis of the MENA beauty and personal care market, highlighting its current and future potential. It provides a detailed examination of market drivers, restraints, challenges, opportunities, and market projections for 2030.

Global Markets for Telemedicine Technologies

Published - Jun 2025 | Publisher - BCC Publishing | Code - HLC014M

The global market for telemedicine technologies is projected to grow from $146.9 billion in 2025 to $251.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 11.3% from 2025 to 2030.

Thermo Fisher Scientific Inc.: 360° Company Analysis

Published - Jun 2025 | Publisher - BCC Publishing | Code - HLC309A

This report provides a comprehensive analysis of Thermo Fisher Scientific Inc., covering key details such as key milestones/history, product offerings, technologies, major applications and end-user industries it serves.

Top Trending Reports

Sensors: Technologies and Global Markets

Published - Jun 2025 | Publisher - BCC Publishing | Code - IAS006Q

The global market for sensors was valued at $195.1 billion in 2024 and is estimated to increase from $212.5 billion in 2025 to reach $323.3 billion by 2030, at a compound annual growth rate (CAGR) of 8.7% from 2025 through 2030.

Global Cell Line and Membrane Market

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO178B

The global market for cell lines and membranes was valued at $5.7 billion in 2024 and is estimated to increase from $6.3 billion in 2025 to reach $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 12.5% from 2025 through 2030.

Water and Wastewater Treatment Technologies: Global Markets

Published - Jun 2025 | Publisher - BCC Publishing | Code - ENV008G

The global market for water and wastewater treatment technologies is expected to grow from $350.7 billion in 2025 and is projected to reach $591.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2025 to 2030.

Global Edge AI Market

Published - Jun 2025 | Publisher - BCC Publishing | Code - IFT310A

The global market for edge AI was valued at $8.7 billion in 2024 and is estimated to increase from $11.8 billion in 2025 to reach $56.8 billion by 2030, at a compound annual growth rate (CAGR) of 36.9% from 2025 through 2030.

2024 Medical Devices Research Review

Published - Mar 2025 | Publisher - BCC Publishing | Code - MDS060B

The medical device industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years These devices treat and diagnose a multitude of patient conditions and work much better than drugs.

Published - Jan-2019| Analyst - BCC Publishing| Code - HLC201B

Report Highlights

The global blood plasma products market should reach $35.5 billion by 2023 from $25.7 billion in 2018 at a compound annual growth rate (CAGR) of 6.6% for the period 2018-2023.

Report Includes

  • 52 data tables and 24 additional tables
  • Industry analysis of the global market for blood plasma products
  • Analyses of global market trends with data from 2017 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Quantification of the global blood plasma products markets by product, application, mode of delivery, end user and geographical region
  • Qualitative information related to mode of delivery for blood plasma
  • Key blood plasma products used in various therapeutic treatments as well as an examination of the supply chain from research to manufacturing
  • Coverage of segmentation of blood plasma products, including immunoglobulin, albumin, protease inhibitors, coagulation factor concentrates and other plasma fractionation products
  • In-depth analysis of the key strategies adopted by industry players, such as acquisition and geographical expansion
  • A look at major factors driving the growth of the global blood plasma products markets, including an organized network of donor centers and rising disease awareness and education
  • Profiles of the major players in the industry, including ADMA Biologics Inc., Baxter International Inc., Creat Group, Octapharma AG, Shire Plc and TCS Biosciences Ltd.
Published - Jul-2017| Analyst - Yojana Jeevane| Code - HLC201A

Report Highlights

The global market for blood plasma reached $16.8 billion in 2016 and should reach $23.0 billion in 2021, growing at a compound annual growth rate (CAGR) of 6.6% from 2016 through 2021.

Report Includes

  • An overview of the global markets for blood plasma products.
  • Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Analysis of the market by product, application, mode of delivery and by end user.
  • Coverage of segmentation of blood plasma products, including immunoglobulin, albumin, protease inhibitors, coagulation factor concentrates and other plasma fractionation products.
  • In-depth analysis of the key strategies adopted by industry players, such as acquisition and geographical expansion.
  • A look at major factors driving the growth of the global blood plasma products markets, including an organized network of donor centers and rising disease awareness and education.
  • Profiles of major players in the industry.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Markets for Blood Plasma Products
Customize Report
AI: Your Say